DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Walpar Nutritions Limited — Board Meeting Intimation

NSE 56 min ago·26 Oct 2026, 9:21 am

Walpar Nutritions

Walpar Nutritions Limited has announced that its board will meet on November 5, 2026, to review and approve the company's unaudited financial results for the first half of the fiscal year ending September 2026. This standard corporate procedure involves the board's review of the company's performance during the interim period.

For investors, this update is a key milestone as it provides an early look at the company's operational health and financial trajectory before the full-year results are released. It offers a chance to assess the company's progress and strategy in the interim.

Investors should watch for the release of these results on or after the meeting date to understand the company's current standing. The data will be crucial for evaluating the stock's future performance.